Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 19-23

  Nielsen, S ^a,d   Dollerup, J ^b   Nielsen, B ^b   Jensen, H AE ^c   Mogensen, C E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MERCK RESEARCH LABORATORIES   (United States)

^c HVIDOVRE HOSPITAL   (Denmark)

^d MAYO CLINIC   (United States)

Author keywords

ACE inhibition; Angiotensin II receptor blocade; Essential hypertension; Urinary albumin excretion

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOSARTAN; PEPTIDE HORMONE ANTAGONIST; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE URINE LEVEL; DOUBLE BLIND PROCEDURE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0030757514     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Brunner FP, Selwood NH. Profile of patients on RRT in Europe and death rates due to major causes of death groups. Kidney Int 1992; 42 [Suppl 38]: S4-S15
2. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Lancet 1988; 2: 530-533
3. Haffner SM, Stern MP, Gruber MKK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990; 10: 727-731
4. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300
5. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabetic Med 1984; 1: 17-19
6. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736-741
7. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360
8. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 26: 1430-1432
9. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93
10. Ritz E, Fliser D. Clinical relevance of albuminuria in hypertensive patients. Clin Invest 1992; 70 Suppl 1: S114-S119
11. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138
12. Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 1995; 10: 1963-1974
13. Anderson S, Brenner BM. Therapeutic implications of converting-enzyme inhibitors in renal disease. Am J Kid Dis 1987; 10: 81-87
14. Tikkanen I, Omvik P, Jensen HAE. Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens 1995; 13: 1343-1351
15. Christensen CK, Ørskov C. Rapid screening PEG immunoassay for quantification of pathological microalbuminuria. Diabetic Nephrol 1984; 3: 92-94
16. Eshøj O, Feldt Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med 1987; 4: 531-533
17. Gatling W, Knight C, Hill RD. Screening for early diabetic nephropathy: which sample to detect microalbuminuria? Diabet Med 1985; 2: 451-455
18. Fabiny DL, Ertinghausen G. Automated reaction-rate method for determination of serum creatinine with the Centrifichem. Clin Chem 1971; 17: 696-700
19. Pontremoli R, Cheli V, Sofia A, et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 1995; 10 [Suppl 6]: 6-9
20. Palatini P, Graniero GR, Mormino P, et al. Prevalence and clinical correlates of microalbuminuria in stage I hypertension. Results from the Hypertension and Ambulatory Recording Venetia Study (HARVEST Study). Am J Hypertens 1996; 9: 334-341
21. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension [published erratum appears in Nephron 1992;62(1):120]. Nephron 1992; 61: 94-97
22. Pedersen EB, Mogensen CE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular rate and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest 1976; 36: 231-237
23. Parving HH, Mogensen CE, Jensen HA, Evrin PE. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974; 1: 1190 1192
24. Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810-815
25. Erley CM, Bader B, Scheu M, Wolf S, Braun N, Risler T. Renal haemodynamics in essential hypertensives treated with losartan. Clinical Nephrology 1995; 43 Suppl 1: S8-11
26. Chen K, Zimmerman BG. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins. J Pharmacol Exp Therapeut 1994; 270: 491-497
27. Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the reninangiotensin system? Kidney Int 1994; 45: 861-867
28. Gansevoort RT, de Zeeuw D, de Jong PE. Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kibney Int 1993; 44: 579-584
29. Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986; 77: 1993-2000